Clinical Trials Logo

Cardiovascular Diseases clinical trials

View clinical trials related to Cardiovascular Diseases.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06330532 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Impact of Preoperative Frailty and Cognitive Impairment on Postoperative Outcomes in Elderly Cardiac Surgery Patients

Start date: March 1, 2024
Phase:
Study type: Observational

This is a retrospective study of patients aged 65 years and older who underwent cardiac and aortic surgery between March 5, 2021 and October 12, 2022 in the operating room of Severance Cardiovascular Hospital to determine the impact of physical frailty as well as nutritional status, emotional dysregulation, and cognitive dysfunction on postoperative outcomes. Physical frailty will be determined by the Clinical Frailty Scale, handgrip strength, and nutritional status, cognitive dysfunction will be determined by the K-MMSE and K-MoCA administered at the preoperative interview, and emotional dysregulation will be determined using the SGDS-K. These were measured during the pre-anesthesia evaluation and only results from patients who agreed to be tested will be used. Nutritional status will be analyzed based on blood test values measured within one month of surgery.

NCT ID: NCT06286618 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Nutrition360: Moving to Integrated and Holistic Disease Prevention Among Underserved Mississippians

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The objective for the study is to implement a pilot study to establish essential components to address diet quality in healthcare settings and examine what value an integrated service model delivery has for the primary prevention of cardiometabolic diseases with an initial focus on dietary behaviors. This objective will be met by 1: Utilizing a multiphase optimization study design to select and optimize essential components to address diet behaviors and 2: Comparing an integrated and referral-based delivery model for healthcare-based strategies that address structural and psychosocial barriers to a healthy diet for racial/ethnic minority, marginalized and disadvantaged background young to middle aged adult populations in Mississippi.

NCT ID: NCT06280859 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Hoosier Sport: Developing and Implementing a Sustainable Campus-Community Partnership in Rural Indiana

Start date: February 20, 2024
Phase: N/A
Study type: Interventional

The clinical trial aims to develop and pilot test a multilevel physical activity (PA) intervention called the Hoosier Sport program. The study follows a participatory co-design protocol involving youth, parents, and community leaders to provide direct input into the intervention's design. The ultimate goal is to contribute to health equity in the community by promoting sustainable physical activity. Hoosier Sport involves delivering enhanced physical education classes, teaching about nutrition and exercise, as well as developing leadership skills in middle school rural students.The intervention will last for 8-weeks with PE classes occur twice a week. Additionally, Hoosier Sport will create more opportunities for students to be active at school (e.g., in home room) through providing virtual classes and other activities.

NCT ID: NCT06190743 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Perception of Cardiovascular Risk

CV-RP
Start date: September 29, 2023
Phase:
Study type: Observational

The aim of the study is to describe the association between the perception of cardiovascular (CV) risk and the actual CV risk and, secondarily, to detect the actual CV risk to assess the prevalence of clinical risk factors, determined by means of appropriate instruments.

NCT ID: NCT06155110 Active, not recruiting - Clinical trials for Cardiovascular Diseases

A Randomized, Single-blind, Controlled Clinical Study of Cardiomyopeptidin on Improving Ischemia-reperfusion Injury in Patients With Acute ST-segment Elevation Myocardial Infarction After Primary PCI

Start date: March 1, 2022
Phase: Phase 4
Study type: Interventional

This study aim to investigate the myocardium protection effect of cardiomyopeptidin in patients undergoing primary PCI for ST-elevation myocardial infarction through myocardial enhanced MRI.

NCT ID: NCT06113484 Active, not recruiting - Clinical trials for Cardiovascular Disease Risk

Impact of a Mediterranean Diet on Cardiovascular Disease Risk Factors

RATE
Start date: June 30, 2023
Phase: N/A
Study type: Interventional

This approved and funded research project is part of a larger project titled "Algarve Active Ageing - Cardiac and Osteoarthritis Rehabilitation (A3-COR): personalized exercise protocol in the rehabilitation after acute myocardial infarction or at risk of cardiovascular disease and knee osteoarthritis, a multicenter clinical intervention study". The main objective of this work is to quantify the effect of a nutritional and physical activity intervention in improving important risk factors for cardiovascular disease, such as body weight, body composition, and waist circumference.

NCT ID: NCT06071351 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Motivational Interviewing Effect on Reducing Cardiovascular Disease Risk Factors

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

Aim: The aim of this study is to examine the effect of motivational interviewing-based training program on reducing cardiovascular disease risk factors in adults. Methods: In the first stage, individuals' CVD risk levels were determined. In the second stage, a 6-session motivational interview-based training program was applied to the intervention group with a medium CVD risk level (HearthSCORE score between 2 and 5 points). Brochures were distributed to the control group.

NCT ID: NCT06047678 Active, not recruiting - Hypertension Clinical Trials

Acute Effect of Individual Variants of Agonist-antagonist and Traditional Agonistic Resistance Training on Cardiovascular Parameters

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

Prevention and non pharmacological treatment of prehypertension and hypertension stage 1 The effect of individual variants of agonist-antagonist and traditional agonistic resistance training on cardiovascular parameters in individuals with normotension and hypertension. What does the study involve? 1. Cardiovascular parameters 2. Body composition 3. Blood tests for heart disease 4. Training intervention A. Resistance training protocol: 75% 1RM, 10 reps, 3 sets, 2 min rest between sets and exercises, 16 exercises 1. Agonistic RT - upper body 2. Agonistic RT - lower body 3. Agonist-Antagonist - upper body 4. Agonist-Antagonist - lower body B. Aerobic training: 60% SF max, 4 x 10 min, 2 min rest between sets 5. Intraabdominal wall tension activity 6. The Borg rating of perceived exertion 7. Handgrip testing 8. Repetition testing (RM)

NCT ID: NCT05977959 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Optimizing the Impact of the Healthy School Recognized Campus Program on Youth's CVD Risk Factors

HSRC
Start date: August 1, 2023
Phase: N/A
Study type: Interventional

Healthy School Recognized Campus is a Texas A&M AgriLife Extension initiative that supports the delivery of school-based physical activity and nutrition programs for diverse youth across Texas. The purpose of this study is to improve the delivery of these programs and optimize the effect they have on youth's cardiovascular risk factors.

NCT ID: NCT05974345 Active, not recruiting - Clinical trials for Atherosclerotic Cardiovascular Disease

In Silico Study Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Patients With Established Cardiovascular Disease

SIRIUS
Start date: November 3, 2023
Phase:
Study type: Observational

Study CKJX839B1FR01 in an In silico trial to predict the efficacy of Inclisiran therapy on major adverse cardiovascular events (MACE) and cardiovascular (CV) death in virtual patients with atherosclerotic cardiovascular disease (ASCVD) and elevated LDL-C.